AURKA KINASE ACTIVITY FRET BIOSENSOR: HCS-FLIM FOR DRUG SCREENING AND OTHER REFINEMENTS
AURKA gene encodes a multifunctional serine/threonine kinase involved in the cell cycle and plays a key role during cell division. The protein is one of the most upstream activator of the mitosis and is involved in the maturation of the centrosomes, the formation of the mitotic spindle and the central spindle. Overexpression of AURKA is a major hallmark of several solid tumors rising from epithelial tissues. So far, no inhibitor of this oncogene has been FDA-approved and therefore it is of great importance to identify new molecules. To be functional, AURKA switch to an activated form through autophosphorylation on the T288 residue leading to a change of conformation.
Our team has developed a FRET (Forster Resonance Energy Transfer) based biosensor for Aurora A consisting of the whole kinase flanking by two fluorophores (Figure 1). We showed that the change of conformation of Aurora A when activated brings closer the fluorophores increasing FRET efficiency and that the biosensor is as functional as the endogenous protein [1]. We have also developed a fast-FLIM prototype (Fluorescence Lifetime Imaging Microscopy) that allows us to image and measure fluorescence lifetime with a higher speed than conventional techniques [2]. As fluorescence lifetime is inversely correlated with FRET efficiency, we are able to track and to image the activation of AURKA within the cells.

Based on this biosensor, we have already investigated new roles of the AurkA kinase in G1 phase for the establishment of the interphase spindle [1] but also at the mitochondria to control organelle dynamics and energy production [3]. Moreover, our project aims to establish a new method to use AURKA FRET biosensor in a HCS-FLIM manner. We have developed an innovative way to perform a rapid and automated drug screening on a 96-well plate to discover new inhibitors of AURKA. Finally, we have also made effort to improve our biosensor both by changing FRET pairs of fluorescent proteins and by using unconventionally two-color FCS to measure FRET at very low level of expression.
[1] Bertolin, G., Sizaire, F., Herbomel, G., Reboutier, D., Prigent, C., and Tramier, M. (2016). A FRET biosensor reveals spatiotemporal activation and functions of aurora kinase A in living cells. Nature Communications 7, 12674.
[2] Leray A, Padilla-Parra S, Roul J, Héliot L, Tramier M. (2013). Spatio-temporal quantification of FRET in living cells by fast Time-Domain FLIM: a comparative study of non-fitting methods. PLOS One 8:e69335.
[3] Bertolin G, Bulteau AL, Alves-Guerra MC, Burel A, Lavault MT, Gavard O, Le Bras S, Gagné JP, Poirier GG, Le Borgne R, Prigent C, Tramier M. (2018). Aurora kinase A localises to mitochondria to control organelle dynamics and energy production. Elife Aug 2;7. pii: e38111.
Date: 19 September 2018, 10:30 (Wednesday, -2nd week, Michaelmas 2018)
Venue: Wellcome Trust Centre for Human Genetics, Headington OX3 7BN
Venue Details: Meeting rooms A & B
Speaker: Dr Marc Tramier (Institute of Genetics & Development Rennes, France)
Organising department: Wellcome Trust Centre for Human Genetics
Organiser: Agata Krupa (Wellcome Centre for Human Genetics, University of Oxford)
Host: Dr Sergi Padilla Parra (University of Oxford)
Part of: Strubi seminars
Booking required?: Not required
Audience: Members of the University only
Editor: Agata Krupa